Pathological mechanisms and advances in neoadjuvant PD-1 blockade combined with chemotherapy for head and neck cancer
Abstract In the most recent edition of Holistic Integrative Oncology, a study by Han and colleagues revealed that combining neoadjuvant programmed cell death 1 (PD-1) blockade with chemotherapy is effective for treating locally advanced head and neck squamous cell carcinoma. The retrospective analys...
Saved in:
| Main Authors: | Yun-jing Hou, Xin-xin Yang, Hong-xue Meng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2024-12-01
|
| Series: | Holistic Integrative Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s44178-024-00140-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Salvage chemotherapy after progression on immunotherapy in recurrent/metastatic squamous cell head and neck carcinoma
by: Sandra Llop, et al.
Published: (2024-11-01) -
Neoadjuvant immunotherapy plus chemotherapy for squamous cell carcinoma of the paranasal sinus: a case report
by: Ying Sun, et al.
Published: (2024-12-01) -
Neoadjuvant chemoimmunotherapy for locally advanced squamous cell carcinoma of the head and neck: Systematic review and meta-analysis
by: Xiayi Zhu, et al.
Published: (2025-02-01) -
The association between body mass index and efficacy of pembrolizumab as second‐line therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma
by: Xinyi Zhang, et al.
Published: (2023-02-01) -
Depth-dependent PD-L1 sampling of head and neck squamous cell carcinoma (HNSCC) – implications for PD-1/PD-L1 checkpoint inhibitor immunotherapy
by: Madhusudan Roy, et al.
Published: (2024-03-01)